VICTORIA MOHN: Open Payments
NPI 1578081873 · MASSILLON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 27 payments from 13 companies in 2025. Trend: 2023 $586 · 2024 $351 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $101 |
| Novo Nordisk Inc | 5 | $93 |
| Neurocrine BioSciences, Inc. | 3 | $63 |
| ABBVIE INC. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
Products named: JARDIANCE, INGREZZA, Ozempic, VRAYLAR, TRELEGY ELLIPTA, BREZTRI, XIFAXAN, GEMTESA.
Industry payments across OH — which companies pay providers there.
